Cargando…
Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a pe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433361/ https://www.ncbi.nlm.nih.gov/pubmed/28328188 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145 |
_version_ | 1783236836629413888 |
---|---|
author | Robinson, Simon Laniado, Marc Montgomery, Bruce |
author_facet | Robinson, Simon Laniado, Marc Montgomery, Bruce |
author_sort | Robinson, Simon |
collection | PubMed |
description | BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a peripheral zone acinar volume and density. With the ratio to the whole gland, we can better predict high grade and all grade cancer. We can model the gland into its acinar and stromal elements. This new “prostatocrit” model could offer more accurate nomograms for biopsy. MATERIALS AND METHODS: 674 patients underwent TRUS and biopsy. Whole gland and zonal volumes were recorded. We compared ratio and acinar volumes when added to a “clinic” model using traditional PSA density. Univariate logistic regression was used to find significant predictors for all and high grade cancer. Backwards multiple logistic regression was used to generate ROC curves comparing the new model to conventional density and PSA alone. OUTCOME AND RESULTS: Prediction of all grades of prostate cancer: significant variables revealed four significant “prostatocrit” parameters: log peripheral zone acinar density; peripheral zone acinar volume/whole gland acinar volume; peripheral zone acinar density/whole gland volume; peripheral zone acinar density. Acinar model (AUC 0.774), clinic model (AUC 0.745) (P=0.0105). Prediction of high grade prostate cancer: peripheral zone acinar density (“prostatocrit”) was the only significant density predictor. Acinar model (AUC 0.811), clinic model (AUC 0.769) (P=0.0005). CONCLUSION: There is renewed use for ratio and “prostatocrit” density of the peripheral zone in predicting cancer. This outperforms all traditional density measurements. |
format | Online Article Text |
id | pubmed-5433361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Urologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-54333612017-05-30 Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” Robinson, Simon Laniado, Marc Montgomery, Bruce Int Braz J Urol Original Article BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a peripheral zone acinar volume and density. With the ratio to the whole gland, we can better predict high grade and all grade cancer. We can model the gland into its acinar and stromal elements. This new “prostatocrit” model could offer more accurate nomograms for biopsy. MATERIALS AND METHODS: 674 patients underwent TRUS and biopsy. Whole gland and zonal volumes were recorded. We compared ratio and acinar volumes when added to a “clinic” model using traditional PSA density. Univariate logistic regression was used to find significant predictors for all and high grade cancer. Backwards multiple logistic regression was used to generate ROC curves comparing the new model to conventional density and PSA alone. OUTCOME AND RESULTS: Prediction of all grades of prostate cancer: significant variables revealed four significant “prostatocrit” parameters: log peripheral zone acinar density; peripheral zone acinar volume/whole gland acinar volume; peripheral zone acinar density/whole gland volume; peripheral zone acinar density. Acinar model (AUC 0.774), clinic model (AUC 0.745) (P=0.0105). Prediction of high grade prostate cancer: peripheral zone acinar density (“prostatocrit”) was the only significant density predictor. Acinar model (AUC 0.811), clinic model (AUC 0.769) (P=0.0005). CONCLUSION: There is renewed use for ratio and “prostatocrit” density of the peripheral zone in predicting cancer. This outperforms all traditional density measurements. Sociedade Brasileira de Urologia 2017 /pmc/articles/PMC5433361/ /pubmed/28328188 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Robinson, Simon Laniado, Marc Montgomery, Bruce Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title | Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title_full | Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title_fullStr | Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title_full_unstemmed | Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title_short | Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” |
title_sort | prostate specific antigen and acinar density: a new dimension, the “prostatocrit” |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433361/ https://www.ncbi.nlm.nih.gov/pubmed/28328188 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145 |
work_keys_str_mv | AT robinsonsimon prostatespecificantigenandacinardensityanewdimensiontheprostatocrit AT laniadomarc prostatespecificantigenandacinardensityanewdimensiontheprostatocrit AT montgomerybruce prostatespecificantigenandacinardensityanewdimensiontheprostatocrit |